Drapalin 1/17 Maluti CBD

Drapalin 1/17 Maluti CBD is a distinctly indica-dominant hybrid of the cultivars Otto Kush and ACDC with minimal psychoactive properties and a high β-myrcene content.

The purple hues on the leaves and buds, as well as the grape aroma, give this unique variety the nickname “Grape Cluster.” Its trichomes produce about 15 – 18% of CBD.

Cultivar
Maluti CBD
(Hybrid, Indica-dominant)
Genetics
Otto Kush x
ACDC
THC- / CBD-Content (w/w)
THC ≤1%
CBD 15,3% bis 18,7%
Shelf life
12 months
Treatment
not irradiated
Producer
MG Health Limited, Lesotho
Main terpenes
β-Myrcene 64%
α-Pinene 19%
β-Caryophyllene 12%
d-Limonene 5%
Properties
soothing
analgesic
anti-inflammatory
antioxidant
antimicrobial
anti-inflammatory
antioxidant
antimicrobial
anti-inflammatory
anxiety-relieving
antidepressant
immunostimulant
Aroma
earthy
fruity
resiny
tangy
spicy
woody
citrusy
fresh
Boiling point
166 – 168 °C
155 °C
130 °C
176 °C

Product videos

Drapalin team visit MG Health 2:07
Production of Medical Cannabis at MG Health 9:45

Areas of Applications

Since the prescription of medical cannabis flowers to patients is a formulation prescription, the decision on the therapeutic area of application rests with the prescribing physician. Based on the symptoms, medical cannabis is currently most frequently used in Germany for the following diseases:
Pain
Anorexia / Cachexia
Depression
Lack of appetite
Insomnia
Spasticity
Inflammatory bowel diseases
Epilepsy
ADHD
Multiple Sclerosis
Tic disorders / Tourette Syndrome
Nausea / Vomiting

Drapalin 1/17 Maluti CBD Product Information

THC ~ 1% CBD ≤ 17%
Effect profile
CBD dominant
  • Anticonvulsant
  • Muscle relaxant
  • Anti-inflammatory
Reccomendation
Clinical evidence based on meta-analysis
  • Epilepsy
  • Morbus Parkinson
  • Anxiety
Medication Intake Medicinal cannabis flowers can be taken both through inhalation (e.g. by means of a vaporizer) and orally (e.g. as a tea preparation). The appropriate route of administration should be determined individually by the prescribing physician together with the patient and must be written down on the prescription.
MG Health is about quality and safety MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level.
„When we started this company, we didn’t just want to make a profit, we wanted to change lives, and what better way to do that than through education and jobs?“ Andre Bothma, CEO of MG Health
These Products are Distributed in Germany by Drapalin Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin.
„We are proud to be the first pharmaceutical wholesaler to supply medical cannabis flowers from Africa to pharmacies throughout Germany since August 2021. In doing so, we have made history together with our Lesotho partner MG Health.“ Lana Korneva, CEO of DRAPALIN